Physician profile
Nitin Kher
NPI 1063512325
$3,582.89
in general payments reported to CMS, 2019-2025
21 companies · $16.40 in 2025
The $16.40 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $658 · 2021: $899 · 2022: $800 · 2023: $521 · 2024: $194 · 2025: $16.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $604.50 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $521.90 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $486.59 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.45 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $322.37 | 2021-2022 | |
| Boston Scientific Corporation | $240.24 | 2019-2021 | |
| Esperion Therapeutics, INC. | $177.96 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $140.71 | 2019-2022 | |
| Pfizer INC. | $131.39 | 2023-2024 | |
| Medtronic Vascular, INC. | $101.82 | 2019 | |
| Medtronic, INC. | $78.59 | 2022-2024 | Corevalve Evolut R |
| Sanofi-Aventis U.S. LLC | $55.92 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $52.56 | 2020-2024 | Farxiga |
| Amarin Pharma, INC. | $49.49 | 2019-2020 | |
| Abbott Laboratories | $36.66 | 2020-2024 | Cardiomems |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $27.93 | 2022 | |
| Angiodynamics, INC. | $20.72 | 2024 | Alphavac |
| Baxter Healthcare | $17.59 | 2023 | |
| Edwards Lifesciences Corporation | $16.95 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bayer Healthcare Pharmaceuticals INC. | $16.40 | 2025 | |
| Cardiovascular Systems INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Kher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.